A Promising Vector for TCR Gene Therapy: Differential Effect of siRNA, 2A Peptide, and Disulfide Bond on the Introduced TCR Expression
Adoptive immunotherapy using TCR gene-modified T-lymphocytes is an attractive strategy for targeting malignancies. However, TCR mispairings between endogenous and introduced TCR chains are a major concern, as they may induce mixed TCRs with unknown specificities and may reduce the expression of ther...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2012-01-01
|
| シリーズ: | Molecular Therapy: Nucleic Acids |
| オンライン・アクセス: | http://www.sciencedirect.com/science/article/pii/S2162253116301184 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
